Literature DB >> 22855199

Changes in calcitropic hormones, bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a controlled cohort study.

U K Møller1, S Streym, L Mosekilde, L Heickendorff, A Flyvbjerg, J Frystyk, L T Jensen, L Rejnmark.   

Abstract

UNLABELLED: Pregnancy and lactation cause major changes in calcium homeostasis and bone metabolism. This population-based cohort study presents the physiological changes in biochemical indices of calcium homeostasis and bone metabolism during pregnancy and lactation
INTRODUCTION: We describe physiological changes in calcium homeostasis, calcitropic hormones and bone metabolism during pregnancy and lactation.
METHODS: We studied 153 women planning pregnancy (n=92 conceived) and 52 non-pregnant, age-matched female controls. Samples were collected prior to pregnancy, once each trimester and 2, 16 and 36 weeks postpartum. The controls were followed in parallel.
RESULTS: P-estradiol (E2), prolactin and 1,25-dihydroxyvitamin D (1,25(OH)2D) increased (p<0.001) during pregnancy, whereas plasma levels of parathyroid hormone (P-PTH) and calcitonin decreased (p<0.01). Insulin-like growth factor I (IGF-I) was suppressed (p<0.05) in early pregnancy but peaked in the third trimester. Postpartum, E2 was low (p<0.05); prolactin decreased according to lactation status (p<0.05). 1,25(OH)2D was normal and IGF-I was again reduced (p<0.05). P-PTH and calcitonin increased postpartum. From early pregnancy, markers of bone resorption and formation rose and fall, respectively (p<0.001). From the third trimester, bone formation markers increased in association with IGF-I changes (p<0.01). Postpartum increases in bone turnover markers were associated with lactation status (p<0.001). During lactation, plasma phosphate was increased, whereas calcium levels tended to be decreased which may stimulate PTH levels during and after prolonged lactation.
CONCLUSION: The increased calcium requirements in early pregnancy are not completely offset by increased intestinal calcium absorption caused by high 1,25(OH)2D since changes in bone markers indicated a negative bone balance. The rise in bone formation in late pregnancy may be initiated by a spike in IGF-I levels. The high bone turnover in lactating women may be related to high prolactin and PTH levels, low E2 levels and perhaps increased parathyroid hormone-related protein levels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855199     DOI: 10.1007/s00198-012-2062-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  57 in total

1.  Parathyroid hormone-related protein levels in maternal and cord blood.

Authors:  Y Hirota; T Anai; I Miyakawa
Journal:  Am J Obstet Gynecol       Date:  1997-09       Impact factor: 8.661

2.  The effect of pregnancy on bone density and bone turnover.

Authors:  K E Naylor; P Iqbal; C Fledelius; R B Fraser; R Eastell
Journal:  J Bone Miner Res       Date:  2000-01       Impact factor: 6.741

3.  Effect of pregnancy and lactation on maternal bone mass and calcium metabolism.

Authors:  G N Kent; R I Price; D H Gutteridge; J R Allen; K J Rosman; M Smith; C I Bhagat; S G Wilson; R W Retallack
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

4.  Assessment of renal function during pregnancy using a random urine protein to creatinine ratio and Cockcroft-Gault formula.

Authors:  K H Quadri; J Bernardini; A Greenberg; S Laifer; A Syed; J L Holley
Journal:  Am J Kidney Dis       Date:  1994-09       Impact factor: 8.860

5.  Serum free 1,25-dihydroxyvitamin D and the free 1,25-dihydroxyvitamin D index during a longitudinal study of human pregnancy and lactation.

Authors:  S G Wilson; R W Retallack; J C Kent; G K Worth; D H Gutteridge
Journal:  Clin Endocrinol (Oxf)       Date:  1990-05       Impact factor: 3.478

6.  The effects of pregnancy and lactation on hormonal status and biochemical markers of bone turnover.

Authors:  Csaba More; Harjit P Bhattoa; Peter Bettembuk; Adam Balogh
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-02-10       Impact factor: 2.435

7.  High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory.

Authors:  Carsten S Højskov; Lene Heickendorff; Holger J Møller
Journal:  Clin Chim Acta       Date:  2009-10-19       Impact factor: 3.786

8.  Does the maternal kidney contribute to the increased circulating 1,25-dihydroxyvitamin D concentrations during pregnancy?

Authors:  M Turner; P E Barré; A Benjamin; D Goltzman; M Gascon-Barré
Journal:  Miner Electrolyte Metab       Date:  1988

9.  Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism.

Authors:  H Dobnig; F Kainer; V Stepan; R Winter; R Lipp; M Schaffer; A Kahr; S Nocnik; G Patterer; G Leb
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

10.  Pattern of bone markers during pregnancy and their changes after delivery.

Authors:  Anna Maria Paoletti; Marisa Orrù; Lucia Floris; Stefano Guerriero; Silvia Ajossa; Sandra Romagnino; Gian Benedetto Melis
Journal:  Horm Res       Date:  2003
View more
  28 in total

Review 1.  Presentation and management of osteoporosis presenting in association with pregnancy or lactation.

Authors:  C S Kovacs; S H Ralston
Journal:  Osteoporos Int       Date:  2015-05-05       Impact factor: 4.507

Review 2.  Vitamin D in pregnancy: current perspectives and future directions.

Authors:  Mairead Kiely; Andrea Hemmingway; Karen M O'Callaghan
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-05-02       Impact factor: 5.346

Review 3.  Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature.

Authors:  M Laroche; M Talibart; C Cormier; C Roux; P Guggenbuhl; Y Degboe
Journal:  Osteoporos Int       Date:  2017-09-06       Impact factor: 4.507

4.  Vitamin D for health: a global perspective.

Authors:  Arash Hossein-nezhad; Michael F Holick
Journal:  Mayo Clin Proc       Date:  2013-06-18       Impact factor: 7.616

5.  Maternal vitamin D biomarkers are associated with maternal and fetal bone turnover among pregnant women consuming controlled amounts of vitamin D, calcium, and phosphorus.

Authors:  Heyjun Park; Patsy M Brannon; Allyson A West; Jian Yan; Xinyin Jiang; Cydne A Perry; Olga Malysheva; Saurabh Mehta; Marie A Caudill
Journal:  Bone       Date:  2016-12-08       Impact factor: 4.398

Review 6.  Maternal and fetal vitamin D and their roles in mineral homeostasis and fetal bone development.

Authors:  B A Ryan; C S Kovacs
Journal:  J Endocrinol Invest       Date:  2020-08-09       Impact factor: 4.256

7.  Vitamin D Status and Gestational Diabetes: Effect of Smoking Status during Pregnancy.

Authors:  Linda Dodds; Christy G Woolcott; Hope Weiler; Anne Spencer; Jean-Claude Forest; B Anthony Armson; Yves Giguère
Journal:  Paediatr Perinat Epidemiol       Date:  2016-02-05       Impact factor: 3.980

8.  Vitamin D supplementation for women during pregnancy.

Authors:  Cristina Palacios; Lia K Kostiuk; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2019-07-26

Review 9.  Regimens of vitamin D supplementation for women during pregnancy.

Authors:  Cristina Palacios; Maria Angelica Trak-Fellermeier; Ricardo X Martinez; Lucero Lopez-Perez; Paul Lips; James A Salisi; Jessica C John; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2019-10-03

10.  Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial.

Authors:  Elizabeth M Curtis; Camille Parsons; Kate Maslin; Stefania D'Angelo; Rebecca J Moon; Sarah R Crozier; Fatma Gossiel; Nicholas J Bishop; Stephen H Kennedy; Aris T Papageorghiou; Robert Fraser; Saurabh V Gandhi; Ann Prentice; Hazel M Inskip; Keith M Godfrey; Inez Schoenmakers; M Kassim Javaid; Richard Eastell; Cyrus Cooper; Nicholas C Harvey
Journal:  Am J Clin Nutr       Date:  2021-11-08       Impact factor: 8.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.